Co-Located Conference AgendasAntibodies and Antibody Drug Conjugates | Drug Discovery India 2016 | 
Thursday, 29 September 2016 |
Draft Agenda- Subject to Change |
| | 08:00 | Registration | 09:00 | Inauguration | 09:20 |  | Conference Chair Welcome Address
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America
|
| 09:40 | | 10:10 | Coffee Break and Networking in the Exhibition Area | |
Session I: Chemical Biology Approaches in Drug Discovery / Session Chair: Dr Divakar Goli |
| | 10:40 |  | Keynote Presentation Development of Peptide-based Synthetic Transcription Factors as Peptide Therapeutics
Siddhartha Roy, Former-Director, IICB; Director, Bose Institute, CSIR-Indian Institute of Chemical Biology, India
|
| 11:10 | Discovery of Novel Dual ATP-Competitive Inhibitors of DNA Gyrase and Topoisomerase IV inspired by Marine Natural Compounds
Danijel Kikelj, Professor, University of Ljubljana, Slovenia
| 11:30 | Lysine Acetylation and Arginine Methylation of Histones are critical for Neural Differentiation and Memory: Probed by Small Molecule Modulators
Tapas Kundu, Professor, JNCASR, India
| 11:50 | System Biology Approaches in Drug Discovery
Nagasuma Chandra, Professor, Indian Institute of Science, India
| 12:10 | Polyphenols for HIV Prophylaxis: A Journey from Discovery to Delivery
Vandana Patravale, Professor, Institute of Chemical Technology, India
This talk will discuss about potential of polyphenols as gp120-CD4 binding inhibitors for prevention of HIV transmission. | 12:30 |  Technology Spotlight:
Advanced Flow Cytometry Solutions and Particle Counting & Characterization in Addressing Your Essential Research Needs
Amitav Mohanty, Manager Market Development, Beckman Coulter, India
Ramanuj Samal, Application Specialist, Beckman Coulter India Pvt Ltd, India
| 12:45 | Lunch Break and Networking in the Exhibition Area | |
Session II: From Natural Products to Drug Candidates / Session Chair: Dr C S Shastry |
| | 13:30 | Drugs from Nature, Drugs from our Ancestors - Tradition to Evidence based Medicines
Pulok K Mukherjee, Director- School of Natural Product Studies, Jadavpur University, India
| 13:50 | | 14:20 | Formulation Development of Herbal Products to get Better Botanical Drug Product
Lal Hingorani, Chairman/ Managing Director, Pharmanza Herbal Pvt. Ltd, India
| 14:40 | Ayurvedic Nootropics for Enhanced Cognition and Protection from Neurodegenerative Diseases
Ashwini Godbole, Senior Assistant Professor, Institute of Transdisciplinary Health Sciences and Technology (TDU), India
| 15:00 | Mining of Traditional Medicine for Drug Discovery and Development
Ashwinikumar Raut, Director, Clinical Research & Integrative Medicine, Kasturba Health Society - Medical Research Centre, India
| 15:20 | Marketing Indian Traditional and Folk medicines and Practices : Need of the Hour
M Arulpitchai Narayanan, Chairman, Arma Medical Foundation, India
| 15:40 | Panel Discussion : Traditional Medicines for Modern time: Challenges
| 16:10 | Coffee Break and Networking in the Exhibition Area | |
Plenary Talk |
| | 16:40 | Skype Talk: Contradiction of Precision Medicine Drugs
Stephen Naylor, Chairman & CEO, MaiHealth Inc & ReNeuroGen LLC , United States of America
| |
Session III: Novel Strategies for Cancer Treatment- I / Session Chair: Dr Vijay Potluri |
| | 17:00 | Engineering Reversal of Drug Resistance in Cancer Cells
Shantanu Chowdhury, Professor, CSIR- Institute of Genomics and Integrative Biology, India
| 17:20 | Targeting Cancer at the Nuclear Pore
Asfar Azmi, Assistant Professor, Wayne State University School of Medicine, United States of America
| 17:40 | Combining Selectivity and Sensitivity for High Confidence Targeted Peptide Quantitation at Low Levels
Russell Watts, Director - Business Development & Marketing, , EMEAI, AB Sciex, United Kingdom
| 18:00 | End of First Day of Conference |
Friday, 30 September 2016 |
Plenary Talk |
| | 09:30 | | |
Session IV: Novel Strategies for Cancer Treatment- II / Session Chair Dr Siddhartha Roy |
| | 10:30 | | 10:50 | Synthesis, Characterization, DNA binding, Anti-Bacterial activity and DFT Calculation of [Ru(Phen)2OHA] and [Co(Phen)2OHA]ClO4 Complexes
Fahmida Khan, Professor & Head, National Institute of Technology, India
| 11:00 | Predicting Clinical Response to Anticancer Drugs using an Ex Vivo Platform that Captures Patient Tumor Microenvironment
Ajith Kamath, Executive Director, Mitra Biotech, India
| 11:25 | Coffee Break and Networking in the Exhibition Area | 11:40 |  Technology Spotlight:
SCIEX & Danaher – Your Partner in Pharmaceutical Analysis
Russell Watts, Director - Business Development & Marketing, , EMEAI, AB Sciex
| |
Session V: Therapies for Infectious & Neglected Tropical Diseases (Session Chair: Dr Saumitra Das, IISc) |
| | 11:55 | Host Pathogen Interaction in Japanese Encephalitis Virus Infection: From Bench to Bedside
Anirban Basu, Senior Scientist, National Brain Research Center, India
| 12:15 | Novel Drugs for Neglected Diseases
Utpal Tatu, Professor, Indian Institute of Science Bangalore, India
| 12:35 | New Class of Glycopeptide Antibiotics: Strategies to Combat Acquired and Intrinsic Bacterial Resistance
Jayanta Haldar, Associate Professor, Jawaharlal Nehru Centre for Advanced Scientific Research, India
| 12:55 | A Possible Strategy to Develop New Inhibitors of Arginase in Helicobacter Gastric Pathogens
Apurba Sau, Scientist, National Institute of Immunology, India
| 13:15 | Identification of Potential Drug Molecules for Melioidosis Treatment
Thomas Antony, Research Director, Aurigene Discovery Technologies Limited, India
| 13:35 | Poster Viewing | 13:45 | Lunch Break and Networking in the Exhibition Area | |
Session VI: Nutraceuticals- An Emerging Paradigm of Drug Discovery / Session Chair: Dr Ashwinikumar Raut |
| | 14:35 | Atherosclerosis: Molecular Mechanisms, Current and Emerging Therapies, and the Potential Of Nutraceuticals In the Prevention/Treatment of this Disease
Dipak Ramji, Professor, Cardiff University, United Kingdom
| 14:55 | Nutraceuticals as Antiobesogenic Lead Molecules
Suman Kapur, Senior Professor & Head , Birla Institute of Technology & Science, Pilani, India
| 15:15 | Coffee Break and Networking in the Exhibition Area | |
SESSION VII: Current Enabling Technologies for Accelerated Drug Discovery / Session Chair: Dr Dipak Ramji |
| | 15:30 | Monitoring Biological Methylation and its Role in Human Health
Said A Goueli, Clinical Professor and Senior Research Fellow, Promega Corporation, United States of America
| 15:50 | Stem Cell and Gene Editing in Drug Discovery
Saumya Pant, Associate Research Director, Biocon Bristol-Myers Squibb India Pvt Ltd, India
| 16:10 | Applications of Centrifugation & Automation Technology in Drug Discovery
Billy Asir, Product Specialist, Beckman Coulter India Pvt Ltd, India
Kalpesh Patil, , Beckman Coulter India Pvt Ltd, India
| 16:30 | Panel Discussion: Drug Discovery and ADC - A Pharma & Biotech Perspective
| 17:10 | Poster Award Presentation | 17:15 | Closing Remarks & Vote of Thanks | 17:20 | End of Conference |
|
Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonDrug Discovery India 2016Drug Discovery India 2016 in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com
